Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3038-3045

  Qadri, Q ^a   Sameer, A S ^a   Shah, Z A ^a   Hamid, A ^a   Alam, S ^a   Manzoor, S ^a   Siddiqi, M A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

GSTP1; Kashmir; Polymorphism; Prostate cancer; Restriction digestion; RFLP

Indexed keywords

ADENOSINE; GLUTATHIONE TRANSFERASE P1; GUANOSINE; ISOLEUCINE; PROSTATE SPECIFIC ANTIGEN; VALINE; GSTP1 PROTEIN, HUMAN;

ADULT; AGE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTP1 GENE; HUMAN; KASHMIRI (PEOPLE); MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; URBAN RURAL DIFFERENCE; ENZYMOLOGY; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; INDIA; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84861822750     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.December.6.4     Document Type: Article

References (34)

1. Abate-Shen C and Shen MM (2000). Molecular genetics of prostate cancer. Genes Dev. 14: 2410-2434.
2. Adler V, Yin Z, Fuchs SY, Benezra M, et al. (1999). Regulation of JNK signaling by GSTp. EMBO J. 18: 1321-1334.
3. Antognelli C, Mearini L, Talesa VN, Giannantoni A, et al. (2005). Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63: 240-251.
4. Autrup JL, Thomassen LH, Olsen JH, Wolf H, et al. (1999). Glutathione S-transferases as risk factors in prostate cancer. Eur. J. Cancer Prev. 8: 525-532.
5. Bostwick DG, Burke HB, Djakiew D, Euling S, et al. (2004). Human prostate cancer risk factors. Cancer 101: 2371-2490.
6. Choi JY, Neuhouser ML, Barnett M, Hudson M, et al. (2007). Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol. Biomarkers Prev. 16: 1115-1120.
7. Debes JD, Yokomizo A, McDonnell SK, Hebbring SJ, et al. (2004). Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet. Cytogenet. 155: 82-86.
8. Fleshner NE and Klotz LH (1998). Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev. 17: 325-330.
9. Garcia-Saez I, Parraga A, Phillips MF, Mantle TJ, et al. (1994). Molecular structure at 1.8 Å of mouse liver class pi glutathione S-transferase complexed with S-(p-nitrobenzyl)glutathione and other inhibitors. J. Mol. Biol. 237: 298-314.
10. Harries LW, Stubbins MJ, Forman D, Howard GC, et al. (1997). Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644.
11. Hayes JD and Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
12. Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, et al. (1998). π-class glutathione S-transferase: regulation and function. Chem. Biol. Interact. 111-112: 69-82.
13. Hsing AW and Chokkalingam AP (2006). Prostate cancer epidemiology. Front. Biosci. 11: 1388-1413.
14. Jeronimo C, Varzim G, Henrique R, Oliveira J, et al. (2002). I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 11: 445-450.
15. Kelada SN, Kardia SL, Walker AH, Wein AJ, et al. (2000). The glutathione S-transferase-mu and-theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol. Biomarkers Prev. 9: 1329-1334.
16. Konwar R, Manchanda PK, Chaudhary P, Nayak VL, et al. (2010). Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pac. J. Cancer Prev. 11: 1067-1072.
17. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, et al. (2001). Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11: 325-330.
18. McCarty KM, Santella RM, Steck SE, Cleveland RJ, et al. (2009). PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ. Health Perspect. 117: 552-558.
19. Mir O, Alexandre J, Tran A, Durand JP, et al. (2009). Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Ann. Oncol. 20: 736-740.
20. Miyake H, Hara I, Kamidono S and Eto H (2004). Oxidative DNA damage in patients with prostate cancer and its response to treatment. J. Urol. 171: 1533-1536.
21. Mo Z, Gao Y, Cao Y, Gao F, et al. (2009). An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 69: 662-688.
22. Nakazato H, Suzuki K, Matsui H, Koike H, et al. (2003). Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res. 23: 2897-2902.
23. Ntais C, Polycarpou A and Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 14: 176-181.
24. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6: 733-743.
25. Ryberg D, Skaug V, Hewer A, Phillips DH, et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289.
26. Shepard TF, Platz EA, Kantoff PW, Nelson WG, et al. (2000). No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol. Biomarkers Prev. 9: 1267-1268.
27. Sikka SC (2003). Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention-a mechanistic approach. Curr. Med. Chem. 10: 2679-2692.
28. Sreeja L, Syamala V, Hariharan S, Syamala VS, et al. (2008). Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J. Exp. Ther. Oncol. 7: 73-85.
29. Srivastava DS, Mandhani A, Mittal B and Mittal RD (2005). Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int. 95: 170-173.
30. Steinhoff C, Franke KH, Golka K, Thier R, et al. (2000). Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch. Toxicol. 74: 521-526.
31. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, et al. (2005). Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Asian Pac. J. Cancer Prev. 6: 309-314.
32. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, et al. (1999). Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9: 333-340.
33. Waris G and Ahsan H (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 5: 14.
34. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, et al. (1994). Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem. 224: 893-899.